REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WITH AT LEAST TWO PRIOR THERAPIES IN BRAZIL E Carmo; PL Lin; P Navaratnam; T Rajput; C Tekle; P Bueno; CC Oliveira; A Freitas;

DARATUMUMAB + BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (DVRD) VS VRD IN TRANSPLANT-INELIGIBLE (TIE)/TRANSPLANT-DEFERRED (TD) NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): PHASE 3 CEPHEUS TRIAL CYTOGENETIC SUBGROUP ANALYSIS NJ Bahlis; SZ Usmani; T Facon; S Zweegman; C Venner; M Braunstein; L Pour; J Marti; A Maiolino; V Hungria;

AVALIAÇÃO DO MICROAMBIENTE MEDULAR NO MIELOMA MÚLTIPLO POR CITOMETRIA DE FLUXO ES Barbosa; ABS Salgado; RM Pontes; RJP Magalhães; EMD Couto; V Valviesse; ES Costa; A Maiolino;